Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 4 Breast Neoplasms 4 Immunoglobulin Light-chain Amyloidosis 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Exanthema 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Ras-wildtype Colorectal Cancer 1 Polyps 1 Polycystic Ovary Syndrome 1 Pleural Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neoplasms, Second Primary 1 Neoplasms 1 Myoma 1 Menstruation Disturbances 1

Interventions

Tablets 1 Doxycycline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Toxicity × Doxycycline × Clear all

NCT03448731 2020-04-08

DERMIA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 2 Completed

Skin Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡